Another interesting molecule expressed by thyroid carcinomas is galectin-3, which has been demonstrated to be overexpressed in more than 94% of thyroid carcinomas, excluding the MTC, while benign thyroid proliferations, such as nodular hyperplasia and adenoma, do not express this marker [52]. This evidence concerns the gene LGALS3 and thyroid gland carcinoma.